Lupus Clinical Trials at North Shore LIJ
 (204 x 53).jpg)
At Last! Although there have been numerous new drugs developed and approved for our sister diseases such as rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis, drug development in SLE has been noticeably quiet.
But, this has all changed in the last year. Approximately 12-20 drugs are in the pipeline for development in SLE; some are further along in the development process than others. The SLE and Autoimmune Disease Treatment Center of the North Shore LIJ Health System, in conjunction with the Program in Novel Therapeutics, is participating in many of these efforts to develop safer and more effective therapies.
At the current time, the SLE and Autoimmune Disease Treatment Center is participating in a half-dozen clinical trials. Each study is looking for different types of patients; some studies require patients with active disease, whereas others require certain levels activity. Eligible patients include:
1. Patients with SLE whose disease is currently inactive
2. Patients with SLE whose disease is currently active but doesn’t involve the kidneys
3. Patients with active kidney disease (lupus nephritis)
4. Patients with inactive kidney disease
5. Patients willing to donate blood for purely observational studies
If you are currently being treated for Systemic Lupus Erythematosus, consider this new study of an investigational SLE Medication
Local doctors are currently conducting a medical research study for patients with chronic moderately to severe active lupus, who have not responded to standard lupus medications. To pre-qualify for this study, you must:
- Be between the ages of 18 and 65
- Have a medical diagnosis of SLE for at least 24 weeks prior to this study
- Be taking at least one oral corticosteroid, amtimalarial or immunosuppressant specifically for SLE.
If you would like more information, on any studies at North Shore LIJ, please contact:
Laura Donohue
(516) 708-2558
The SLE and Autoimmune Disease Treatment Center
Division of Rheumatology
North Shore LIJ Health System
Another trial looking for participants at North Shore LIJ
If You Have SYSTEMIC LUPUS ERYTHEMATOSUS, you might want to participate in a research study testing an investigational drug, known as a phytochemical, which means it is a chemical that comes from plants. This investigational drug is also a commercially available product found in vegetables such as cabbage.
Sponsored by
The Program in Novel Therapeutics
Division of Rheumatology and Allergy-Clinical Immunology
North Shore – Long Island Jewish Health System
Lake Success, NY
For information please call 516-708-2557